New Leaf Ventures Names Martin Mackay, Ph.D., as Senior Advisor Seasoned Biopharma R&D Executive Brings More Than 30 Years of Expertise to New Leaf and Its Portfolio of Healthcare and Technology Companies NEW YORK–(BUSINESS WIRE)–New Leaf Venture...
New Leaf Venture Partners Closes $310 Million Healthcare Fund; Focus on Clinical-Stage Biopharmaceutical Products, Early-Stage Medical Devices, and Molecular Diagnostics NEW YORK & MENLO PARK, Calif. Aug. 9, 2005 — New Leaf Venture Partners (NLV Partners)...
New Leaf Venture Partners Names Milton B. McColl, M.D. as Venture Partner NEW YORK & MENLO PARK, Calif. – April 16, 2007 – New Leaf Venture Partners (NLV Partners) announced today the appointment of Milton B. McColl, M.D. as a venture partner. Dr. McColl most...
New Leaf Venture Partners Closes $450 Million Healthcare Fund NEW YORK & MENLO PARK, Calif.–Oct. 10, 2007–New Leaf Venture Partners, L.L.C. (“NLV Partners”) today announced the closing of New Leaf Ventures II, L.P. (“NLV-II”), a...
New Leaf Venture Partners Appoints Dr. Srinivas Akkaraju as Managing Director and Lead of the Firm’s West Coast Biopharmaceuticals Practice NEW YORK–(BUSINESS WIRE)– New Leaf Venture Partners (NLV Partners) announced today the appointment of Srinivas...
Recent Comments